Evidence map›Paper›PMID 28076792›Full record

ArticleCell reports2017

The Mre11-Nbs1 Interface Is Essential for Viability and Tumor Suppression.

Jun Hyun Kim, Malgorzata Grosbart, Roopesh Anand, Claire Wyman, Petr Cejka, John H J Petrini

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Crystal structure of the folded domains of Xrs2 from Saccharomyces cerevisiae.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  5. Article
  6. Review
  7. NBS1 facilitates preribosomal RNA biogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Importance of Germline and Somatic Alterations in HumanInternational journal of molecular sciences · 2023
    Review
  10. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  11. Article
  12. DNA damage and repair in the hematopoietic system.Acta biochimica et biophysica Sinica · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. The Role ofInternational journal of molecular sciences · 2021
    Review
  17. Review
  18. Article
  19. Checkpoint Responses to DNA Double-Strand Breaks.Annual review of biochemistry · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Jun Hyun KimMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Malgorzata GrosbartDepartment of Molecular Genetics, Erasmus University Medical Center, 3000 Rotterdam, the Netherlands; Department of Radiation Oncology, Erasmus University Medical Center, 3000 Rotterdam, the Netherlands.
Roopesh AnandInstitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.
Claire WymanDepartment of Molecular Genetics, Erasmus University Medical Center, 3000 Rotterdam, the Netherlands; Department of Radiation Oncology, Erasmus University Medical Center, 3000 Rotterdam, the Netherlands.
Petr CejkaInstitute for Research in Biomedicine, Università della Svizzera Italiana, Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.
John H J PetriniMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. Electronic address: petrinij@mskcc.org.
Erasmus MC · NLMemorial Sloan Kettering Cancer Center · USUniversità della Svizzera italiana · CH

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
MSKCC Pilot Center for Precision Disease ModelingU54OD020355 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI LOWE, SCOTT W., SOLIT, DAVID B. · 2015 to 2019
$9.9M
Regulation of the DNA damage response by the Mre11 complexR37GM059413 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PETRINI, JOHN HJ · 2012 to 2020
$5.2M
The Mre11 complex: linking recombination to checkpointsR01GM059413 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1999 to 2011
$5.2M
The Proneural Perivascular Niche and Therapeutic ResponseU54CA163167 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, JASON · 2011 to 2015
$4.6M
Functional analysis of Chk2 in DNA damage responseF32GM105296 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI KIM, JUN HYUN · 2013 to 2013
$55k
FASEB SRC on Genetic Recombination and Genome RearrangementsR13CA162528 · NCI · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · PI PETRINI, JOHN HJ · 2011 to 2011
$5k
NCI NIH HHS P30 CA008748NCI NIH HHS R13 CA162528NCI NIH HHS U54 CA163167NIGMS NIH HHS F32 GM105296NIGMS NIH HHS R01 GM059413NIGMS NIH HHS R37 GM059413NIH HHS U54 OD020355
6 · The paper itself

Abstract

The Mre11 complex (Mre11, Rad50, and Nbs1) is integral to both DNA repair and ataxia telangiectasia mutated (ATM)-dependent DNA damage signaling. All three Mre11 complex components are essential for viability at the cellular and organismal levels. To delineate essential and non-essential Mre11 complex functions that are mediated by Nbs1, we used TALEN-based genome editing to derive Nbs1 mutant mice (Nbs1

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsCarcinogenesisCell Cycle ProteinsCell SurvivalConserved SequenceDNA-Binding ProteinsDNA DamageDNA RepairEmbryonic DevelopmentEvolution, MolecularFetusHematopoiesisLiverMiceCell Cycle ProteinsDNA-Binding ProteinsMre11a protein, mouseMRE11 Homologue ProteinNijmegen breakage syndrome 1 protein, mouseNuclear ProteinsTumor Suppressor ProteinsATM activationMre11 complex assemblyMre11-Nbs1 interfaceNbs1(mid) mutants

Identifiers

PMID28076792
PMCPMC5234850
OpenAlexW2570865181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.